AGP Picks
View all

Maryland Tech Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Maryland Tech Journal.

Press releases published on May 19, 2026

Arctera and Enterprise Vault Expand Leadership Team with New Sales Leaders to Drive Strategic Growth
BrainHQ Awarded the Gold: Earns Trusted Digital Badge from APA Labs, a unit of American Psychological Association Services, Inc.
Worldwide NFT, Inc. Announces Change of Control, Recapitalization
D-Orbit and ELECTRA AI Sign MoU to Bring AI Battery Intelligence to Space
Onconetix, Inc. Announces 1-for-10 Reverse Stock Split
Aduro Clean Technologies to List on the Toronto Stock Exchange
Trident Digital Tech Holdings Ltd. (Nasdaq: TDTH) Unveils Five-Pillar Digital Infrastructure Holding Company Strategy Across Africa and Asia-Pacific
Locafy Transitioning Customers to AEO Subscription Services in Coming Months
Rezolve Ai Solves the 26% AI Distortion Crisis Stalling Global Retail; Peer-Reviewed Research Validates Near-Perfect Accuracy
Xunlei Limited Schedules 2026 Unaudited First Quarter Earnings Release on May 28, 2026
Inspira Technologies to Begin Trading as QTREX Quantum Under Nasdaq Ticker "QTEX" on May 20, 2026, Following Strategic Focus on AME and Quantum Connectivity
SNS Bondholders Secure Compensation Settlements Following Dutch Ministry Deadline
Plus Therapeutics Partners with Ephemeral Technologies to Deploy AI Execution Platform for CNS Oncology
Vertero Advances into Phase 1b Study with VT-5006 for the Treatment of Parkinson’s Disease
Alterity Therapeutics Data Presentations Support Advancement of ATH434 into Phase 3 in Multiple System Atrophy
SiTime Corporation Announces Proposed Convertible Senior Notes Offering
Zenas BioPharma Announces Upcoming Presentation of Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD) at EULAR 2026 Congress
Vanqua Bio to Present Positive Biomarker Data from Ongoing Phase 1b Study at Upcoming Medical Conferences
Quantum Cyber Files Patent with USPTO for Autonomous Naval Mine Countermeasure System Addressing Iran's Mining of the Strait of Hormuz and Trump Administration Homeland Security Priorities
Cullinan Therapeutics Receives FDA Orphan Drug Designation for CLN-049, a Novel FLT3xCD3 T Cell Engager, in Relapsed/Refractory Acute Myeloid Leukemia

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Maryland Tech Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.